Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

114.51

-0.36 (0.31%)

as of Jun 10, 2026, 8:00:00 pm Market Open.

214 watching

Investor Insights

Jun 9, 2026, 12:00 am

This summary was created by AI, based on 32 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) continues to evoke mixed opinions from experts, with many emphasizing its valuable proprietary data, especially for legal and accounting sectors. Some analysts recognize its potential to leverage AI technologies to enhance efficiency and product offerings. However, concerns around valuation persist, particularly with the stock's historical high PE ratios and recent downward trends. While there are varying perspectives on how AI may disrupt its core business, some analysts see TRI's unique data moat as a strong competitive advantage that may help it maintain resilience. Overall, while there are advocates for its long-term potential, there are also cautionary notes regarding its current market assessment and future revenue impacts from technological advancements.

Consensus

Hold

Valuation

Fair Value

Similar

Bloomberg, BDN

SELL

There are better places to put your money.

BUY

Re-focusing and selling some pieces in order to be an e-business. Looking at 8% to 12% growth. High quality and pays a dividend.

DON'T BUY

This is a great company, but thinks the stock will continue to go sideways. Growth rate is rather anaemic and the multiple is extremely high.

BUY

Unloading their Learning Division for $5 billion. Likes their focus on new management.

TOP PICK

A very defensive company but has solid growth. Organic growth of 7 to 9%. Likely to increase the dividend at a 10% annual rate. In none economic sensitive areas.

TOP PICK

Starting to make substantial moves into engineering, sciences, etc besides their current legal and medical areas. Have been investing their capital into the new areas and it is starting to show results. Seeing consistent increases in revenues. ROE has been improving quarter after quarter.

DON'T BUY

Trades at a fairly lofty multiple. Showing modest growth. Trading on the more expensive side.

COMMENT

Really great company. Most of their earnings come out of the US so with earnings growth converted back to Cdn$, it has done nothing over the last few years. Internal growth has been 7%. Spending $300 million over the next 3 years to cut costs and will save $150 million a year. A little expensive.

BUY ON WEAKNESS

Has traditionally been more expensive on a price/earnings ratio than what he likes to pay. A first-rate company. The demand for information they supply will keep on growing. Would buy it at $40.

PAST TOP PICK

(A Top Pick Aug 2/05. Up 4%.) The story is very much intact and unfolding the way he expected. Starting to drive the values in synergies out of their acquisitions and starting to drive the earnings growth.

BUY ON WEAKNESS

Finally starting to generate the organic growth. Latest was at about 7%. Good defensive name. Not cheap. An attractive investment for medium to longer term.

DON'T BUY

A well-run business. Provide a lot of data products. Valuation is always fairly rich.

TOP PICK

Surprised everyone on the upside with their latest report. Announced a program going forward called Thomson Plus, concentrating less on acquisitions and more on efficiency. Putting a larger model of $’s towards this. Sales increased about 7% in the last quarter.

PAST TOP PICK

(A Top Pick May 2/06. Down 3%.) Likes it because it's not on anybody's radar screen. Large and well capitalised. Good business model.

HOLD

Made a lot of investments over the last several years. It appears those investments are starting to pay off. In the last few months, shares have started to act better. Earnings growth rose to 63% in the last quarter. One of a few companies on the TSX that looks attractive.

Showing 466 to 480 of 710 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)